Henry ScheinHSICEarnings & Financial Report
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners. For 14 consecutive years, the company has been named as one of the World's Most Ethical Companies by Ethisphere, most recently in 2025.
Revenue
$3.2B
Gross Profit
$993.0M
Operating Profit
$155.0M
Net Profit
$94.0M
Gross Margin
31.1%
Operating Margin
4.9%
Net Margin
2.9%
YoY Growth
5.8%
EPS
$0.75
Henry Schein Q4 FY2024 Financial Summary
Henry Schein reported revenue of $3.2B (up 5.8% YoY) for Q4 FY2024, with a net profit of $94.0M (up 422.2% YoY) (2.9% margin). Cost of goods sold was $2.2B, operating expenses totaled $838.0M.
Key Financial Metrics
| Total Revenue | $3.2B |
|---|---|
| Net Profit | $94.0M |
| Gross Margin | 31.1% |
| Operating Margin | 4.9% |
| Report Period | Q4 FY2024 |
Henry Schein Annual Revenue by Year
Henry Schein annual revenue history includes year-by-year totals (for example, 2025 revenue was $13.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $13.2B |
| 2024 | $12.7B |
| 2022 | $12.6B |
Henry Schein Quarterly Revenue & Net Profit History
Henry Schein results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $3.4B | +7.7% | $101.0M | 2.9% |
| Q3 FY2025 | $3.3B | +5.2% | $101.0M | 3.0% |
| Q2 FY2025 | $3.2B | +3.3% | $86.0M | 2.7% |
| Q1 FY2025 | $3.2B | -0.1% | $110.0M | 3.5% |
| Q4 FY2024 | $3.2B | +5.8% | $94.0M | 2.9% |
| Q3 FY2024 | $3.2B | +0.4% | $99.0M | 3.1% |
| Q2 FY2024 | $3.1B | +2.5% | $104.0M | 3.3% |
| Q1 FY2024 | $3.2B | — | $93.0M | 2.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.17B | $3.14B | $3.17B | $3.19B | $3.17B | $3.24B | $3.34B | $3.44B |
| YoY Growth | N/A | 2.5% | 0.4% | 5.8% | -0.1% | 3.3% | 5.2% | 7.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $10.14B | $10.25B | $10.61B | $10.22B | $10.48B | $10.91B | $11.10B | $11.21B |
| Liabilities | $5.11B | $5.25B | $5.63B | $5.38B | $5.76B | $6.01B | $6.20B | $6.42B |
| Equity | $3.60B | $3.51B | $3.50B | $3.39B | $3.31B | $3.44B | $3.36B | $3.25B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $197.0M | $296.0M | $151.0M | $204.0M | $37.0M | $120.0M | $174.0M | $381.0M |